cytarabine has been researched along with Teratocarcinoma in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hohjoh, H; Omi, K; Tokunaga, K | 1 |
Ballmer-Hofer, K; Klemenz, R; Marty, C; Neri, D; Odermatt, B; Schott, H; Schwendener, RA | 1 |
2 other study(ies) available for cytarabine and Teratocarcinoma
Article | Year |
---|---|
Long-lasting RNAi activity in mammalian neurons.
Topics: Animals; Apoptosis; Cell Differentiation; Cell Division; Cell Line, Tumor; Cells, Cultured; Cytarabine; Gene Expression Profiling; Hippocampus; Mice; Mice, Inbred ICR; Neurons; RNA, Double-Stranded; RNA, Small Interfering; Teratocarcinoma; Time Factors; Tretinoin | 2004 |
Cytotoxic targeting of F9 teratocarcinoma tumours with anti-ED-B fibronectin scFv antibody modified liposomes.
Topics: Animals; Antibodies, Neoplasm; Antineoplastic Agents; Cytarabine; Female; Fibronectins; Fluorodeoxyuridylate; Immunoglobulin Fragments; Injections, Intravenous; Liposomes; Male; Mice; Mice, Nude; Teratocarcinoma; Testicular Neoplasms; Tissue Distribution; Tumor Cells, Cultured | 2002 |